Kovai Medical Center and Hospital Limited has scheduled its 40th Annual General Meeting (AGM) for Wednesday, August 26, 2026, to transact business including the adoption of financial statements. The meeting will be held via Video Conferencing (VC) or Other Audio Visual Means (OAVM) starting at 11:00 a.m. IST, ensuring shareholder participation counts toward quorum under Section 103 of the Companies Act 2013. This virtual format aligns with ongoing regulatory guidelines from the Ministry of Corporate Affairs and SEBI.

Key Dates and Deadlines

Shareholders must note specific deadlines regarding voting eligibility and share transfers. The register of members and share transfer books will remain closed from Thursday, August 20, 2026, through Wednesday, August 26, 2026. Only those holding shares as of the cut-off date, August 19, 2026, are eligible to vote.

E-Voting Process

Remote e-voting commences on Sunday, August 23, 2026, at 9:00 a.m. and concludes on Tuesday, August 25, 2026, at 5:00 p.m. Votes cast during this window cannot be changed subsequently. Shareholders who have not voted remotely may cast their votes during the AGM via VC/OAVM. However, those who have already voted remotely are eligible to attend the meeting but cannot vote again.

Login credentials for e-voting are being sent to registered email IDs. Shareholders registered with NSDL can use existing user IDs and passwords. New members acquiring shares after the notice dispatch but before the cut-off date can obtain login details by contacting evoting@nsdl.co.in or the Registrar and Transfer Agent, M/s GNSA Infotech Private Limited, at sta@gnsaindia.com .

Regulatory Compliance and Scrutiny

The company appointed Mr. K. Duraisami, Practising Company Secretary, as the Scrutinizer to ensure a fair and transparent voting process. The results will be announced on the company’s website and communicated to BSE Limited. The notice was published in "Trinity Mirror" and "Makkal Kural" on July 29, 2026, pursuant to Regulation 30 of SEBI (LODR) Regulations 2015.

kovai medical center hospital reported a net profit after tax (PAT) of ₹24,446.00 lakhs for the financial year ended March 31, 2026, marking a 17% increase from ₹20,894.62 lakhs in the previous year. The growth was driven by a 15.65% rise in operating income to ₹1,58,563.68 lakhs, reflecting strong occupancy rates and higher average revenue per occupied bed. Earnings before interest, tax, depreciation, and amortization (EBITDA) climbed to ₹46,710.23 lakhs from ₹40,781.69 lakhs, maintaining a robust margin of 29%. The Board of Directors recommended a final dividend of ₹15 per equity share, subject to shareholder approval at the upcoming Annual General Meeting (AGM).

The AGM is scheduled for August 26, 2026, to be held via video conference or other audio-visual means. Shareholders will vote on the adoption of financial statements, the declaration of dividends, and the reappointment of Dr. M.C. Thirumoorthi as a director liable to retire by rotation. Additionally, the meeting will address the reappointment of M/s RKMS & Associates as Cost Auditor for FY2026-27 with a remuneration of ₹6,50,000 plus GST. Remote e-voting will be available from August 23 to August 25, 2026, with the record date set for August 19, 2026.

Financial Performance

Revenue from operations expanded significantly across both healthcare and education segments. Inpatient revenues grew by 15.02% to ₹1,05,824.86 lakhs, while outpatient revenues increased by 14.94% to ₹41,051.23 lakhs. The education segment contributed ₹11,539.07 lakhs, up 24.68% from the previous year, following the launch of postgraduate programs. Total expenses rose to ₹1,28,819.27 lakhs from ₹1,11,566.36 lakhs, primarily due to higher employee benefits and consultant charges, which scaled in line with revenue growth.

Operational Highlights

The company expanded its infrastructure with a ₹120 crore investment in the new Institute of Neuro Sciences & OPD Block, inaugurated in January 2026. This facility includes Tamil Nadu’s first AI-driven Neuro Radiology Center. Clinical milestones included performing 1,000 robotic-assisted knee replacements and recording 75 ECMO runs in 2025, the highest in the state. The Board also approved the construction of a 300-bed Paediatric Hospital, with work expected to commence in the second quarter of 2026.

What the Numbers Show

A key analytical observation is the efficiency gain in cost management despite aggressive capital expenditure. While depreciation and amortization expenses increased by ₹1,180.74 lakhs to ₹10,939.40 lakhs due to additions of ₹2,937.30 crore in capital assets, finance costs decreased slightly to ₹3,201.69 lakhs. This indicates that internal cash flows are sufficiently strong to service debt without relying on additional external borrowing, reinforcing the company’s conservative leverage profile and stable credit rating of CRISIL AA-/Stable.